|
TB-Related Articles
Return to TB-Related Articles
Table of Contents
Journal Articles Published by Division of TB
Elimination (DTBE) Authors
January - December 2003
Lobato MN, Mohle-Boetani JC, Royce SE. Yield of source-case
and contact investigations in identifying previously undiagnosed
tuberculosis. Int J Tuberc Lung Dis 2003; 7(Suppl. 3): 5391-5396.
Adatu F, Odeke R, Mugenyi M, Gargioni G, McCray E, Schneider E,
and Maher D. Implementation of the DOTS strategy for tuberculosis
control in rural Kiboga District, Uganda, offering patients the
option of treatment supervision in the community, 1998-1999. Int
J Tuberc Lung Dis 2003 Sep; 7(9, Suppl 1): S63-S71.
Burman W, Breese P, Weis S, Bock N, Bernardo J, Vernon A and the
TB Trials Consortium. The effects of local review on informed consent
documents from a multicenter clinical trials consortium. Controlled
Clinical Trials 2003 (June); 24(3): 245-255.
Frieden T R, Sterling T R, Munsiff S S, Watt C J, and Dye C. Tuberculosis.
Lancet 2003 Sep 13; 362 (9387): 887-899.
Frieden TR and Driver CR. Tuberculosis control: past 10 years and
future progress. Tuberculosis 2003: 83(1-3): 82-85.
Frieden TR and Khatri GR. Impact of national consultants on successful
expansion of effective tuberculosis control in India. Int J Tuberc
Lung Dis 2003 Sep; 7(9): 837-841.
Garber E, San Gabriel P, Lambert L, and Saiman L. A survey of latent
tuberculosis infection among laboratory healthcare workers in New
York City. Infection Control and Hospital Epidemiology 2003
Nov; 24(11): 801-6.
Kherosheva T, Thorpe L E, Kiryanova E, Rybka L, Gerasichev V, Shulgina
M, Nemtsova E, Aptekar T, Kluge H, Jakubowiak W, Grzemska M, Aquino
G, Wells C, and Kazionny B. Encouraging outcomes in the first year
of a TB control demonstration program: Orel Oblast, Russia. Int
J Tuberc Lung Dis 2003 Nov; 7(11): 1045-1051.
Kim D Y, Ridzon R, Giles B, Mireles T, Garrity K, Hathcock A L,
Crowder D, Jackson R, and Taylor Z. A no-name tuberculosis tracking
system. Am J Public Health 2003 Oct; 93(10): 1637-1639.
Koppaka VR, Harvey E, Mertz B, Johnson BA. Risk factors associated
with tuberculin skin test positivity among university students and
the use of such factors in the development of a targeted screening
program. Clin Infect Dis 2003 Mar 1; 36(5): 599-607.
Larson J L, Lambert L, Stricof R L, Driscoll J, McGarry M A, and
Ridzon R. Potential nosocomial exposure to Mycobacterium tuberculosis
from a bronchoscope. Infection Control and Hospital Epidemiology
2003 Nov; 24(11): 825-30.
Li JH, Driver CR, Munsiff SS, Yip R, and Fujiwara PI. Differential
decline in tuberculosis incidence among US- and non-US-born persons
in New York City. Int J Tuberc Lung Dis 2003 May; 7(5): 451-457.
Lobato MN, Leary L, Simone P. Treatment of latent TB in correctional
facilities, a challenge for TB elimination. Am J Prev Med
2003; 24(3): 249-253.
LoBue P A and Moser K S. Use of isoniazid for latent tuberculosis
infection in a public health clinic. Am J Respir Crit Care Med
2003 Aug 15; 168(4): 443-447.
LoBue PA, Betacourt W, Peter C, Moser KS. Epidemiology of Mycobacterium
bovis disease in San Diego County, 1994-2000. Int J Tuberc
Lung Dis 2003 Feb; 7(2): 180-5.
Lockman S, Hone N, Kenyon TA, et al. Etiology of pulmonary infections
in predominantly HIV-infected adults with suspected tuberculosis,
Botswana. Int J Tuberc Lung Dis 2003 Aug; 7(8): 714-723.
Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Iademarco
MF. Detection of Mycobacterium tuberculosis infection by whole-blood
interferon-release assay. Clin + Dis 2003:36; 1207-1208.
Letter to editor.
McElroy PD, Southwick KL, Fortenberry ER, Levine EC, Diem LA, Woodley
CL, Williams PM, McCarthy KD, Ridzon R, Leone PA. Outbreak of tuberculosis
among homeless persons coinfected with human immunodeficiency virus.
Clin Infect Dis 2003; 36: 1305-12.
McLaughlin SI, Spradling P, Drociuk D, Ridzon R, Pozsik CJ, and
Onorato I. Extensive transmission of Mycobacterium tuberculosis
among congregated, HIV-infected prison inmates in South Carolina,
United States. Int J Tuberc Lung Dis 2003 Jul; 7(7): 665-672.
Moalosi G, Floyd K, Phatshwane J, Moeti T, Binkin N, and Kenyon
T. Cost-effectiveness of home-based care versus hospital care for
chronically ill tuberculosis patients, Francistown, Botswana. Int
J Tuberc Lung Dis 2003 Sep; 7(9, Suppl 1): S80-S85.
Morozova I, Riekstina V, Sture G, Wells C, and Leimane V. Impact
of the growing HIV-1 epidemic on multidrug-resistant tuberculosis
control in Latvia. Int J Tuberc Lung Dis 2003 Sep; 7(9):
903-906.
Mosimaneotsile B, Talbot E A, Moeti T L, Hone N M, Moalosi G, Moffat
H J, Lee E J, and Kenyon T A. Value of chest radiography in a tuberculosis
prevention programme for HIV-infected people, Botswana. Lancet
2003 Nov 8; 362 (9395): 1551-2.
Munsiff SS, Nivin B, Sacajiu G, Mathema B, Bifani P, and Kreiswirth
BN. Persistence of a highly resistant strain of tuberculosis in
New York City during 1990-1999. J
Infect Dis 2003 Aug 1; 188 (3): 356-63.
Nuermberger EL, Yoshimatsu T, Tyagi S, O'Brien RJ, Vernon AN, Chaisson
RE, Bishai WR, Grosset JH. Moxifloxacin-containing regimen
greatly reduces time to culture conversion in murine tuberculosis.
Am J Respir Crit Care Med
2003 Oct 24 [Epub ahead of print].
O'Brien RJ. Development of fluoroquinolones as first-line
drugs for tuberculosis--at long last! Am
J Respir Crit Care Med 2003 Dec 1;168(11):1266-8.
Radhakrishna S, Frieden T R, and Subramani R. Association of initial
tuberculin sensitivity, age, and sex with the incidence of tuberculosis
in South India: a 15-year follow-up. Int J Tuberc Lung Dis
2003 Nov; 7(11): 1083-1091.
Reichard AA, Lobato MN, Roberts CA, Bazerman LB, Hammett TM.
Assessment of tuberculosis screening and management practices of
large jail systems. Public Health Rep 2003 Nov-Dec;118(6):
500-507.
Schneider E and Castro KG. Tuberculosis trends in the United States,
1992-2001. Tuberculosis 2003; 83(1-3): 21-29.
Selvakumar N, Govindan D, Chandu NA, Frieden TR, Narayanan PR.
Processing sputum specimens in a refrigerated centrifuge does not
increase the rate of isolation of Mycobacterium tuberculosis. J
Clin Microbiol 2003 Jan; 41(1): 469-71.
Sterling TR, Lehmann HP, Frieden TR. Impact of DOTS compared with
DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths:
decision analysis. BMJ 2003 Mar 15; 326: 574-79.
Talbot EA, Hone NM, Moffat HJ, et al. The validity of HIV testing
using sputum from suspected tuberculosis patients, Botswana, 2001.
Int J Tuberc Lung Dis 2003 Aug; 7(8): 710-713.
Talbot EA, Kenyon TA, Mwasekaga MJ, Moeti TL, Mallon V, and Binkin
NJ. Control of anti-tuberculosis drug resistance in Botswana. Int
J Tuberc Lung Dis 2003 Jan; 7(1): 72-77.
Uthaivoravit W, Yanai H, Tappero JW, et al. Impact of enhanced
notification of tuberculosis laboratory results to minimise treatment
delay, Chiang Rai Hospital, Northern Thailand. Int J Tuberc Lung
Dis 2003 Jan; 7(1): 46-51.
Weiner M, Burman W, Vernon A, et al. Low isoniazid concentrations
and outcome of tuberculosis treatment with once-weekly isoniazid
and rifapentine. Am J Respir Crit Care Med 2003 May 15; 167(10):
1341-1347.
White MC, Gournis E, Kawamura M, Menendez E, and Tulsky JP. Effect
of directly observed preventive therapy for latent tuberculosis
infection in San Francisco. Int J Tuberc Lung Dis 2003 Jan;
7(1): 30-35.
Last Reviewed: 05/18/2008 Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
|